SEQUELS Trademark

Trademark Overview


On Monday, November 17, 1958, a trademark application was filed for SEQUELS with the United States Patent and Trademark Office. The USPTO has given the SEQUELS trademark a serial number of 72062509. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Saturday, December 23, 2000. This trademark is owned by AMERICAN CYANAMID COMPANY. The SEQUELS trademark is filed in the Pharmaceutical Products category with the following description:

HUMAN PHARMACEUTICALS IN SUSTAINED RELEASE DOSAGE FORMS

General Information


Serial Number72062509
Word MarkSEQUELS
Filing DateMonday, November 17, 1958
Status710 - CANCELLED - SECTION 8
Status DateSaturday, December 23, 2000
Registration Number0683164
Registration DateTuesday, August 11, 1959
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesHUMAN PHARMACEUTICALS IN SUSTAINED RELEASE DOSAGE FORMS

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes018
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateSaturday, December 23, 2000
Primary Code018
First Use Anywhere DateTuesday, November 4, 1958
First Use In Commerce DateTuesday, November 4, 1958

Trademark Owner History


Party NameAMERICAN CYANAMID COMPANY
Party Type40 - New Owner After Registration
Legal Entity Type98 - Unknown
AddressWAYNE N.J.

Party NameAMERICAN CYANAMID COMPANY
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNEW YORK, NY

Trademark Events


Event DateEvent Description
Saturday, December 23, 2000CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Saturday, August 11, 1979REGISTERED AND RENEWED (FIRST RENEWAL - 20 YRS)